Bone Metabolism in Patients with Primary Hyperparathyroidism Before and After Surgery

Abstract

Primary hyperparathyroidism (PHPT) is accompanied with a reduced bone mineral density (BMD) and an increased risk of fracture. Surgery is the only option for cure. It is hypothesized that in patients with PHPT bone metabolism normalizes after parathyroidectomy (PTX) and that BMD gradually increases. Fifty-two patients with PHPT who underwent surgery were prospectively followed for 1 year. Biochemical analyses were performed at baseline and 1, 4, 7 days; 6 weeks; and 3, 6, and 12 months, and BMD before and one year after surgery. Parathyroid hormone (PTH), calcium, and the bone resorption marker dropped immediately, but transiently after PTX, bone formation decreased more slowly. Osteoprotegerin (OPG) as well as cathepsin K did not show significant changes. BMD of the lumbar spine, but not of the femoral neck, increased significantly within one year after surgery. Moderate correlations existed between the changes of total calcium, ionized calcium, as well as bone-specific alkaline phosphatase and changes of the lumbar BMD. Patients who needed postoperative supplementation with calcium and vitamin D had significantly higher PTH levels. Some gender-specific differences in patients with PHPT were observed. In patients with PHPT, males appear to be more severely affected than females. Within the first year after PTX, bone metabolism normalized, and BMD of the lumbar spine increased. Patients who needed a supplementation with calcium and vitamin D after PTX preoperatively had higher serum levels of PTH.

Key words

primary hyperparathyroidism - surgery - bone metabolism - gender - OPG - cathepsin K

• References

• 1 Eriksen EF, Mosekilde L, Melsen F. Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone 1986; 7: 213-221
• 2 Pietschmann P, Niederle B, Anvari A, Woloszczuk W. Serum osteocalcin levels in primary hyperparathyroidism. Klin Wochenschr 1991; 69: 351-353
• 3 Christiansen P, Steiniche T, Vesterby A, Mosekilde L, Hessov I, Melsen F. Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 1992; 13: 41-49
• 4 Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K. Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 2003; 88: 4655-4658
• 5 Khosla S, Melton III LJ, Wermers RA, Crpwsn CS, O’Fallong WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 1999; 14: 1700-1707
• 6 Gittoes NJL, Cooper MS. Primary hyperparathyroidism – is mild disease worth treating?. Clin Med 2010; 10: 45-49
• 7 Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol 2007; 143: 31-48
• 8 Fraher U, Watson PH, Kisiel M, Natale BV, Hodsman AB. Measurement of circulating osteoprotegerin (OPG) in human sera: inhibition of circulating OPG in osteoporotic patients treated with hPTH (1-34). ASBMR; Toronto: 2000. (abstract)
• 9 Nakchbandi IA, Lang R, Kinder B, Insogna KL. The role of the receptor activator of nuclear factor-kB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism. J Clin Endocrinol Metab 2008; 93: 967-973
• 10 Stilgren LS, Hegedüs LM, Beck-Nielsen H, Abrahamsen B. Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. Calcif Tissue Int 2003; 73: 210-216
• 11 Stilgren LS, Rettmer E, Hegedüs LM, Beck-Nielsen H, Abrahamsen B. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-κB ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. Bone 2004; 35: 256-265
• 12 Hesch RD. Die konservative Therapie des extrarenalen Hyperparathyroidismus. In: Beyer J, Krause U. (eds.). Therapie des Hyperparathyroidismus. Stuttart: Schattauer; 1981: 51-69
• 13 Prager G, Czerny C, Kurtaran A, Passler C, Scheuba C, Bieglmayer C, Niederle B. Minimally invasive open parathyroidectomy in an endemic goiter area: a prospective study. Arch Surg 2001; 36: 810-816
• 14 Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B. A “defined baseline” in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery 2007; 142: 398-404
• 15 Tanaka Y, Naruse T, Funahashi H, Imai T, Suzumura K, Mase T, Tominaga Y. Bone metabolic analysis in patients with primary hyperparathyroidism. Biomed Pharmacother 2000; 54 (Suppl. 01) 97s-99s
• 16 Garton M, Martin J, Stewart A, Krukowski Z, Matheson N, Robins S, Loveridge N, Reid D. Changes in bone mass and metabolism after surgery for primary hyperparathyroidism. Clin Endocrinol 1995; 42: 493-500
• 17 Davies C, Demeure St MJ, John A, Edis AJ. Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy. World J Surg 1990; 14: 355-360
• 18 Carty SE, Roberts MM, Virji MA, Haywood L, Yim JH. Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism. Surgery 2002; 132: 1086-1093
• 19 Biskobing DM. Significance of elevated parathyroid hormone after parathyroidectomy. Endocrine Practice 2010; 16: 112-117
• 20 Nordenstöm E, Westerdahl J, Bergenfelz A. Long-term follow-up of patients with elevated PTH levels following successful exploration for primary hyperparathyroidism. World J Surg 2004; 28: 570-575
• 21 Guo CY, Holland PA, Jackson BF, Hannon RA, Rogers A, Harrison BJ, Eastell R. Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism. Eur J Endocrinol 2000; 142: 451-459
• 22 Lumachi F, Ermani M, Basso SM, Camozzi V, Nardi A, Favia G, Luisetto G. Short- and long-term changes in bone mineral density of the lumbar spine after parathyroidectomy in patients with primary hyperthyroidism. Calcif Tissue Int 2003; 73: 44-48
• 23 Ominsky MS, Stolina M, Li X, Corbin TJ, Asuncion FJ, Barrero M, Niu QT, Dwyer D, Adamu S, Warmington KS, Grisanti M, Tan HL, Ke HZ, Simonet WS, Kostenuik PJ. One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density and strength. J Bone Miner Res 2009; 24: 1234-1246
• 24 Drake MT, Srinivasan B, Mödder UI, Peterson JM, McCready LK, Riggs BL, Dwyer D, Stolina M, Kostenuik P, Khosla S. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endorcinol Metabol 2010; 95: 5056-5062
• 25 Muñoz-Torres M, Reyes-García R, Mezquita-Raya P, Fernández-García D, Alonso G, Luna Jde D, Ruiz-Requena ME, Escobar-Jiménez F. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate. Maturitas 2009; 64: 188-192
• 26 Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, Mosekilde L. Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone 1999; 25: 237-244
• 27 Hagström E, Lundgren E, Mallmin H, Rastad J, Hellman P. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J Int Med 2006; 259: 191-198
• 28 Sitges-Serra A, Prieto R, Pena MJ, Nogues X, Sancho JJ. Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women. Br J Surg 2010; 97: 1013-1019
• 29 Lumachi F, Camozzi V, Ermani M, Naradi A, Luisetto G. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender. Ann NY Acad Sci 2007; 1117: 362-366
• 30 Eriksen EF. Primary hyperparathyroidism: lessons from bone histomorphometry. JBMR 2002; 17: N95-N97
• 31 Siilin H, Lundgren E, Mallmin H, Mellström D, Ohlsson C, Karlsson M, Orwoll E, Ljunggren O. Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World J Surg 2011; 35: 1266-1272